Viral vector platforms

From plasmid to virus: one-stop vector solutions

Lentivirus, adenovirus, AAV and retrovirus packaging that supports your work from basic research through preclinical development.

Explore viral packaging Request a quote

Core business lines

From viral vector packaging to process development, FuBio covers the gene delivery workflow end to end.

Why choose FuBio

Platform technology, production capacity, quality assurance and delivery speed.

  • Platform technology

    In-house lentiviral and AAV packaging systems with capsid and promoter engineering, so vector designs are not limited to off-the-shelf parts.

  • Production capacity

    BSL-2 compliant laboratories and coordinated production sites covering both stock products and custom batches.

  • Quality assurance

    ISO 9001 aligned quality management with in-process controls and a certificate of analysis issued with every batch.

  • Delivery speed

    Stock vectors ship immediately and standard packaging projects are delivered in 3-5 business days, with an expedited option.

Viral vector platforms
4
Catalog products
234
Ready-to-use cell lines
145
Standard packaging lead time
3-5 days

What our clients say

  • Vector quality control is rigorous and delivery is consistent, which suits both our basic research and our investigator-initiated trial work. A dependable long-term partner for gene delivery in the laboratory.

    Principal investigator, university research group

  • FuBio capacity and one-stop vector services shortened the CMC development timeline for our pipeline. Their scalable delivery capability materially reduces supply chain risk for drug development.

    Chief scientific officer, biopharmaceutical company

  • The quality system is demanding and the viral vector material is well controlled, which supports our department gene therapy clinical research and translation work.

    Professor, tertiary referral hospital

  • The integrated capability from gene delivery through process development is mature, and the technical team works deep in vector fundamentals. An essential partner as our pipeline moves from early research toward IND filing.

    Founder, gene therapy company

  • 2017 Founded
  • 1000+ Projects delivered
  • 3500㎡ R&D and production base
  • Suzhou Headquarters

About FuBio

Future Biotechnology

FuBio (Suzhou) Biotechnology is a gene delivery and biopharmaceutical CRO founded in 2017. We build on self-developed viral packaging, stable cell line engineering and targeted screening platforms to serve life science research, cell and gene therapy, in vitro diagnostics and vaccine development.

The company provides end-to-end support from vector design and process development through preclinical evaluation, with the mission of making gene therapy broadly accessible.

Our laboratories include BSL-2 cell culture suites, viral vector handling rooms and plasmid preparation areas, supported by flow cytometry, qPCR and live-cell imaging instrumentation.

  • Innovation
  • Expertise
  • Responsibility
  • Shared success
Company profile
Bioreactors and culture flasks in a vector production laboratory

News and updates

All news

Discuss your vector project with our team

Tell us the vector, payload and scale you need. We reply with a feasibility assessment, lead time and quotation within one business day.

Request a quote